Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung Biologics (207940) – iM Securities | Annual Operating Profit Surpasses KRW 2T · Pure-CDMO Transition · Three-Pillar Growth Strategy / 2026-01-22 Research
  • [Research] Samsung Biologics (207940) – iM Securities | US Site Operation · K-CDMO Policy Support · Order Pipeline Optimization / 2026-04-23 Research
  • [Research] SK hynix (000660 / SKHY) – Yuanta | AI Inference · Enterprise SSD · Cash Flow / 2026-01-29 Research
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Memory ASP · Server Demand · Earnings Upgrades / 2026-03-31 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Commencing Customer T ESS Business (Estimated) · SDC Asset Utilization · Valuation Gap Narrowing / 2026-02-03 Research
  • [Research] LIG D&A (079550) – Hanwha Investment & Securities | 3Q25 Review · Secured Growth Materialization · Expanding Export Share / 2025-11-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI Server Demand · Supply Deficit · FCBGA Technical Bottleneck / 2026-07-20 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | 4Q Earnings Recovery · New Plant Ramp-up · Peptide Expansion / 2026-07-24 Research

[Research] SK hynix (000660 / SKHY) – Mirae Asset | Agentic AI · Server CPU · LPDDR / 2026-04-28

Posted on April 28, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Mirae Asset Securities

Analyst : Younggun Kim

Investment Rating : BUY (Maintained)

Target Price : KRW 2,000,000 (Upgraded)

Core Momentum : The shift from AI training toward inference and agentic AI is expected to accelerate server CPU demand and expand conventional DRAM and LPDDR requirements, while next-generation LPDDR6 adoption provides an additional high-value memory growth opportunity.

📊 1. [Valuation & Key Financial Metrics]

  • Equity Research Date: April 28, 2026
  • Investment Rating: BUY (Maintained) / Target Price (Upgraded): KRW 2,000,000
  • Current Price (as of 26/4/27): KRW 1,292,000 / Upside Potential: 54.8%
  • Operating Profit (26F, KRW bn): 279,225 / Consensus Operating Profit (26F, KRW bn): 241,796
  • EPS Growth (26F, %): 395.8 / MKT EPS Growth (26F, %): 203.0
  • P/E (26F, x): 4.4 / MKT P/E (26F, x): 7.9 / KOSPI: 6,615.03
  • Market Capitalization: KRW 920,811 billion / Shares Outstanding (mn shares): 713 / Float Ratio (%): 75.0
  • Foreign Ownership (%): 53.1 / Beta (12M) Daily Return: 1.60
  • 52-Week Low / High (KRW): 177,500 / 1,292,000
  • FY 2026F Estimates: Revenue KRW 355,195 bn, Operating Profit KRW 279,225 bn, Net Income KRW 208,794 bn, EPS KRW 292,281, ROE 93.3%, P/E 4.4x, P/B 2.8x, Dividend Yield 0.3%
  • FY 2027F Estimates: Revenue KRW 564,125 bn, Operating Profit KRW 459,335 bn, Net Income KRW 349,985 bn, EPS KRW 491,067, ROE 69.9%, P/E 2.6x, P/B 1.4x, Dividend Yield 0.6%

🚀 2. [Market Opportunities & Business Outlook]

  • The target price has been raised by 20% to KRW 2.0 million (from KRW 1,660,000), applying the global pure memory peer average P/B multiple of 3.4x to the 12-month forward BPS of KRW 601,967 (26F basis).
  • Until 1Q26, margin surges were accompanied by ASP increases amid limited shipments due to cost constraints, but volume growth is set to accelerate starting in 2Q, driving continuous top-line expansion. Estimated operating profits for 2Q26F, 26F, and 27F are KRW 64.4 trillion (QoQ +71%), KRW 279 trillion (YoY +492%), and KRW 459 trillion (YoY +65%), respectively.
  • Google’s training-focused TPU v8t expanded HBM3E capacity from 192GB to 216GB, while the inference-focused TPU v8i increased HBM3E by +50% to 288GB compared to v7, alongside a 3x expansion in SRAM to 384MB, underscoring rising memory dependency in inference workloads.
  • As AI workloads transition from training to inference and agentic AI, the GPU-to-CPU attachment ratio is rising from 8:1 to 4:1 and 1:1 or higher, driving strong server CPU demand that directly translates into conventional DRAM and LPDDR requirements.
  • NVIDIA’s transition from Vera to its next-generation CPU (expected as Rosa) increases the probability of LPDDR6 adoption, following SK hynix’s introduction of 16Gb LPDDR6 DRAM based on the 1c nm process at ISSCC 2026, achieving a peak transfer speed of 14.4Gb/s/pin.

📝 Editor’s Comment (Perspective & Thesis Verification)

The analyst evaluates SK hynix not merely as an HBM beneficiary, but as a core enterprise capturing exploding server CPU and LPDDR demand amid the proliferation of agentic AI. With ROE approaching 90% and P/B standing at a modest 2.x level, market focus should shift away from basic growth rates toward margin sustainability and structural valuation re-rating.

To determine whether this investment thesis is actively unfolding, key monitoring items include tracking whether second-quarter volume growth materializes alongside the projected KRW 64.4 trillion operating profit. In addition, it is necessary to verify changes in the GPU-to-CPU attachment ratio driven by advanced AI workloads and examine conventional memory mix improvements from next-generation standards like LPDDR6. These developments can be tracked through corporate earnings reports and official IR disclosures.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Failure · Grabody Platforms · Intrinsic Value / 2026-04-28
Next Post: [Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28

Related Posts

  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | ADR Listing · SOX Inclusion · HBM Pricing / 2026-06-25 Research
  • [Research] LIG D&A (079550) – Eugene Investment & Securities | Non-Cheongung Potential · High-margin Legacy Defense · Earnings Surprise / 2026-05-08 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Supply Constraints · Earnings Surge / 2026-05-11 Research
  • [Research] Samsung Biologics (207940) – Hana Securities | Rockville Revenue Recognition · Guidance Revision Potential · Plant 5 Commercialization / 2026-04-23 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Memory Pricing · LTA · Supplier Pricing Power / 2026-04-06 Research
  • [Research] Samsung SDI (006400) – Hanwha Investment & Securities | Delayed EV Recovery · ESS Highlights as Sole Driver · Target Price Cut / 2026-01-07 Research
  • [Research] Celltrion (068270) – Daishin Securities | Merger Noise Resolution · Portfolio Expansion Leverage · CMO Revenue Visibility / 2026-05-19 Research
  • [Research] SK hynix (000660 / SKHY) – Kyobo | AI Server Demand · Memory ASP · High-Value Product Mix / 2026-01-30 Research
  • [Research] Hanwha Ocean (042660) – DS Investment & Securities | Merchant Vessel Profitability · High-Price Mix · MASGA Beneficiary / 2026-07-28 Research
  • [Research] LigaChem Biosciences (141080) – iM Securities | Platform Valuation · Pipeline Milestones · Deal Expansion / 2025-08-12 Research
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM · eSSD · Margin Expansion / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Server DRAM · eSSD · Earnings Upgrades / 2026-04-09 Research
  • [Research] LIG D&A (079550) – SK Securities | Modern Warfare Leader · Limited Global CapEx · Multiple Re-rating / 2026-04-07 Research
  • [Research] Celltrion (068270) – Mirae Asset Securities | New Product Mix Expansion · In-House Cost Efficiency · Valuation vs Peers / 2026-07-28 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme